REVA’s 2-year clinical results speak for themselves! Our Fantom Encore bioresorbable scaffolds yield lower rates of target lesion failure, compared to similar competing #heartdisease devices. At REVA, we strive every day to make #healthcare advances for patients and doctors.
Thinking about trying a vegan diet? 🥦 New research suggests that a plant-based regimen may help prevent heart disease!
The study finds that going vegan is anti-inflammatory by reducing a protein linked to adverse cardiovascular events: https://t.co/GPjVumzFlF
REVA's core #innovation is a proprietary polymer derived from the amino acid tyrosine. “Tyrocore” is naturally biocompatible and resorbed after completing its therapeutic function – reducing complications and expanding future treatment options. Read more: https://t.co/lG797IbHQT
The year’s best 100 heart programs are in! Check out the list of US hospitals and health systems: https://t.co/FqAT02j4mm #CardioTwitter#Cardiology#Hospitals
Recent studies show that of the 10 most common prescriptions in Australia, 8 of them relate to #hearthealth. In 2017-2018 medications for blood pressure and cholesterol management cost Australians close to $100 million. #CardioFacts#Australia#HealthHealthy#CardioTwittter
@DrKoltowski Congratulations on a successful procedure and thank you for working with us! Everyone at REVA is thrilled to see the first image of Fantom, four years after implantation - tremendous #medtech progress for better #hearthealth!
First image of REVA’s Fantom bioresorbable scaffold at four years, with excellent vessel healing! ❤️ Stay tuned for an exciting update in #cardiology and #medtech!
Baseline vs. 4-year OCT follow-up of BVS Fantom implantation. Complete healing. No clinical events since. 2nd generation scaffolds bring back the concept of coronary restoration therapy, but careful evaluation is needed. #EAPCI#PCROnline
Did you know that 1 pint of donated blood can save up to 3 lives? January is National Blood Donor Month. Donate and give the gift of life. For more information: https://t.co/sUJUFb12n1 #save3lives#DonateBlood#HeartofREVA
What a tremendous week it has been in San Francisco at the J.P. Morgan Healthcare Conference! The future of #healthcare and medical device development is looking bright! #JPM19@bioweeksf@jpmorgan
We a thrilled to attend the 37th Annual J.P. Morgan Healthcare Conference this week in San Francisco. Our team is looking forward to learning from and connecting with #healthcare giants from around the world. #JPM19@bioweeksf@jpmorgan
“Patients come first. If you think what you’re doing is better for patients, whatever roadblock, whatever challenge comes in front of you, it’s easy,” said Reggie Groves, CEO of REVA. Read more about her patient first perspective in @SarahsDDNews article: https://t.co/22o34aCE9o
It’s 2019! Let’s take extra care of our #HeartHealth this month.
Did you know that heart attacks spike during the holidays, associated with heavy alcohol consumption and overeating? Read more about “Holiday Heart Syndrome”: https://t.co/TxhqH2T8Pc #CardioTwitter#HeartofREVA
What is the future of #medtech? ⚕️
REVA’s CEO, Reggie Groves, reveals her predictions for the top 3 trends in 2019 #healthcare. Listen to The Future in a Flash podcast to learn more: https://t.co/JlsQgi8ePT #JPM19
Is a BRS right for your #patient? REVA wants Fantom Encore to be used in the right patient with the right #lesion. It is important to consider a patient’s age, health conditions, and the location and severity of blockage. Learn more here: https://t.co/DurhEigsnf #CardioTwitter
Before you visit your #doctor, make sure you understand your options. Do some research. Fantom Encore isn’t right for everyone, but it might be right for you! To learn more visit: https://t.co/Ywizu09KpF
Happy holidays from the entire REVA team. Today we would like to remind everyone how important it is to take care of your #heart! Eat healthy, exercise and don’t stress too much! #HeartofREVA
“Getting the heart condition, which was very sudden, it changed my way of life totally,” Clause Brogger, retired airline #pilot and Fantom BRS recipient. To understand the impact of REVA’s #technology, it is important to understand a #patient’s #individual story. #CardioTwitter
The AHA recommends 40 minutes of aerobic exercise three to four times a week. Walking is a great form of cardiovascular exercise! Visit: https://t.co/yb1GDRZIxd @SanDiegoHeart
REVA’s Fantom product line offers #physicians the procedural ease that they expect. Straightforward delivery, single-step inflation and a large margin for post dilation. Accuracy matters! #CardioTwitter